Opinions
John Sinkins, CFA
Medimmune
MEDI-Q
TOP PICK
Dec 08, 2003
Has a flu virus vaccine and they expect sales will pick up. They have other respiratory products which continue to do well.
$27.850
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.